Webinars and Sponsored Roundtables — Register Now

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice

Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Marketplace Directory

SPE product for urine drug testing

June 2018—Phenomenex introduced Strata-X-Drug B Plus, a solid-phase extraction sample preparation product for urine drug testing in clinical and forensic toxicology laboratories.

Cascade Pathology Services joins Aurora Diagnostics

June 2018—Aurora Diagnostics announced that Cascade Pathology Services, a physician-owned multispecialty pathology practice providing surgical pathology services to hospitals and physician groups in the Portland area, has joined Aurora Diagnostics.

Beckman introduces Access Sensitive Estradiol

June 2018—Beckman Coulter Diagnostics launched its Access Sensitive Estradiol in the U.S. and in the majority of worldwide markets. The assay aims to help laboratories deliver more accurate results for patients seeking answers to reproductive health questions.

SciGene FISH hybridizer

June 2018—SciGene introduced the CytoBrite Plus Slide Incubation System, a programmable FISH hybridizer with onboard temperature verification of each slide position, as required by CAP cytogenetics checklist item CYG.33950.

IgG subclass antibodies

June 2018—Binding Site’s Immunologicals Group announced the availability of affinity-purified, unconjugated, anti-human antibodies to the IgG subclasses, including IgG1, IgG2, IgG3, and IgG4, for IVD research use in solid phase enzyme immunoassay based test methods, especially ELISAs, and other potential testing applications.

Genoptix completes Rosetta acquisition

June 2018—Rosetta Genomics’ stockholders have approved the acquisition of the company by Genoptix, which will immediately begin marketing, selling, and distributing Rosetta Genomics’ products.

POC immunoassay testing system

June 2018—Sekisui Diagnostics has partnered with Qualigen to distribute the FastPack IP System, Qualigen’s POC immunoassay testing system.